Conmed (CNMD) Misses Q2 EPS by 8c, Maintains FY15 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. JBLU
6. ANT
7. AAPL
8. SSD
9. ARTV
10. AGYS

Go back to Conmed (CNMD) Misses Q2 EPS by 8c, Maintains FY15 Guidance

Northland Capital Markets Downgrades CONMED (CNMD) to Market Perform

July 22, 2015 7:19 AM EDT

Northland Capital Markets downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $58.00 (from $65.00), saying 2nd-half guidance may be too optimistic.

Analyst Mark Landy commented, "CNMD reported in line 2Q revenues of $181M but missed our and the... More

Needham & Company Raises Price Target to $60 Following Conmed's (CNMD) 2Q Miss

July 22, 2015 6:58 AM EDT

Needham & Company reiterated a Buy rating on CONMED (NASDAQ: CNMD), and raised the price target to $60.00 (from $56.00), following 2Q15. CNMD's reported revenue was $181.0M vs. consensus of $182.3M. EPS was $0.36 vs. consensus of $0.44. Analyst Mike Matson said that investors may give management the benefit of... More